Application 088365

Type
ANDA
Sponsor
HIKMA PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CHLOROTHIAZIDE AND RESERPINECHLOROTHIAZIDE; RESERPINETABLET;ORAL500MG;0.125MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A088365-001CHLOROTHIAZIDE AND RESERPINECHLOROTHIAZIDE; RESERPINE500MG;0.125MGTABLET / ORAL1983-12-22
A088365-002CHLOROTHIAZIDE AND RESERPINECHLOROTHIAZIDE; RESERPINE250MG;0.125MGTABLET / ORAL1983-12-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 2 · 49 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A088365-001CHLOROTHIAZIDE AND RESERPINE500MG;0.125MGTABLET / ORAL1983-12-22a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A088365-001CHLOROTHIAZIDE AND RESERPINE500MG;0.125MGTABLET / ORAL1983-12-223f0d92c62455…
2023-05-13 08:27 UTC2023-05A088365-001CHLOROTHIAZIDE AND RESERPINE500MG;0.125MGTABLET / ORAL1983-12-22053a50430f4f…
2023-01-26 05:58 UTC2023-01A088365-001CHLOROTHIAZIDE AND RESERPINE500MG;0.125MGTABLET / ORAL1983-12-223bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A088365-001CHLOROTHIAZIDE AND RESERPINE500MG;0.125MGTABLET / ORAL1983-12-223a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A088365-001CHLOROTHIAZIDE AND RESERPINE500MG;0.125MGTABLET / ORAL1983-12-22f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A088365-001CHLOROTHIAZIDE AND RESERPINE500MG;0.125MGTABLET / ORAL1983-12-22e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A088365-001CHLOROTHIAZIDE AND RESERPINE500MG;0.125MGTABLET / ORAL1983-12-22cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A088365-001CHLOROTHIAZIDE AND RESERPINE500MG;0.125MGTABLET / ORAL1983-12-22a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.